Research workbench
Crystal structure of broadly and potently neutralizing antibody VRC01 in complex with HIV-1 clade C strain ZM176.66 GP120
Analyse Crystal structure of broadly and potently neutralizing antibody VRC01 in… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.
- PDB
- 4LST
- Type
- protein
- Length
- 771 residues
- Chains
- 3
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Envelope glycoprotein GP120 of HIV-1 clade C; Heavy chain of antibody VRC01; Light chain…
- UniProt
- R4GRV3
- Ligands
- NAG
- Pockets
- 9 · best druggability 0.75
Structure
x-ray diffraction · 3 distinct chains · 11% helix, 43% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| G | Envelope glycoprotein GP120 of HIV-1 clade C | protein | 339 | 17% helix, 36% strand | R4GRV3 |
| H | Heavy chain of antibody VRC01 | protein | 222 | 7% helix, 48% strand | — |
| L | Light chain of antibody VRC01 | protein | 210 | 6% helix, 50% strand | — |
Ligands and binding sites
- NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 8 copies · chains G, L
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
9 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 347 | 0.75 | 0.86 | 42 | empty |
| 2 | 154 | 0.74 | 0.92 | 33 | empty |
| 3 | 202 | 0.68 | 0.86 | 24 | empty |
| 4 | 296 | 0.64 | 0.81 | 43 | empty |
| 5 | 60 | 0.50 | 0.86 | 20 | empty |
Interfaces
3 interfaces between chains.
- H–L · 1919 Ų buried · 13 hydrogen bonds · protein-protein
- G–H · 1039 Ų buried · 17 hydrogen bonds · protein-protein
- G–L · 356 Ų buried · 7 hydrogen bonds · protein-protein
Modifications
Observed in the structure: 13 disulfide, 8 glycan (disulfide, N-glycosylation).
Compared structures
- 4LST · Crystal structure of broadly and potently neutralizing antibody VRC01 in complex with… · the same entry in another collection · chain L against L, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt R4GRV3
- Elsewhere: RCSB PDB 4LST · PDBe 4LST · UniProt R4GRV3
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.